Home › Funds › TRAPHAGEN INVESTMENT ADVISORS LLC › CME

TRAPHAGEN INVESTMENT ADVISORS LLC position in CME

CME GROUP INC · Financials

TRAPHAGEN INVESTMENT ADVISORS LLC reported holding 48,615 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$12.7M, representing 0.87% of its reported portfolio and ranking #21 among its reported holdings. TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)48.62K sh
Reported value held$12.74M
Portfolio Weight0.87%
First reportedQ3 2023
Last changeHold
Updated2026-10-14

Last updated: 2026-10-14 · Source: SEC EDGAR Form 13F-HR

How TRAPHAGEN INVESTMENT ADVISORS LLC's CME position evolved

TRAPHAGEN INVESTMENT ADVISORS LLC first disclosed a stake in CME in Q3 2023 at 48,480 shares (US$9.7M). The position peaked in Q1 2026 at 48,555 shares, worth US$14.3M. Across 13 filings, TRAPHAGEN INVESTMENT ADVISORS LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 48,615 shares valued at US$12.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 48.48K $9.71M New
Q4 2023 48.48K $10.21M Hold
Q1 2024 48.49K $10.44M Hold
Q2 2024 48.49K $9.53M Hold
Q3 2024 48.50K $10.70M Hold
Q4 2024 48.50K $11.26M Hold
Q1 2025 48.51K $12.87M Hold
Q2 2025 48.52K $13.37M Hold
Q3 2025 48.52K $13.11M Hold
Q4 2025 48.54K $13.25M Hold
Q1 2026 48.55K $14.34M Hold
Q2 2026 48.59K $10.73M Hold
Q3 2026 48.62K $12.74M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CME and 13F data

CME (CME GROUP INC) is a Financials company. 27 other funds we track also report a position in CME — the largest reported positions include Banque Cantonale Vaudoise (US$3.33B), Sanders Capital, LLC (US$1.12B), RAYMOND JAMES FINANCIAL INC (US$896.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CME

All CME fund holders →

FAQ

How long has TRAPHAGEN INVESTMENT ADVISORS LLC held CME?

TRAPHAGEN INVESTMENT ADVISORS LLC has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TRAPHAGEN INVESTMENT ADVISORS LLC's current position in CME?

As of Q3 2026, TRAPHAGEN INVESTMENT ADVISORS LLC holds 48.62K shares of CME (CME GROUP INC), valued at $12.74M, representing 0.87% of its reported portfolio and ranking #21.

Has TRAPHAGEN INVESTMENT ADVISORS LLC been buying or selling CME?

In the latest 13F filing (Q3 2026), TRAPHAGEN INVESTMENT ADVISORS LLC held unchanged its position in CME. The position peaked in Q1 2026 at 48.55K shares.

Which other funds hold CME?

Other major institutional holders of CME include Banque Cantonale Vaudoise, Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.